Lansoprazole Patent Expiration
Lansoprazole was first introduced by Takeda Pharmaceuticals Usa Inc
Lansoprazole Patents
Given below is the list of patents protecting Lansoprazole, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Lansoprazole | US11077055 | Orally disintegrating compositions | Apr 21, 2036 | Dexcel |
| Lansoprazole | US11986554 | Orally disintegrating compositions | Apr 21, 2036 | Dexcel |
| Prevacid Iv |
US7396841 (Pediatric) | Injections |
Feb 17, 2022
(Expired) | Takeda Pharms Na |
| Prevacid Iv | US7396841 | Injections |
Aug 17, 2021
(Expired) | Takeda Pharms Na |
| Prevacid |
US6328994 (Pediatric) | Orally disintegrable tablets |
Nov 17, 2019
(Expired) | Takeda Pharms Usa |
| Prevacid |
US7431942 (Pediatric) | Orally disintegrable tablets |
Nov 17, 2019
(Expired) | Takeda Pharms Usa |
| Prevacid |
US7875292 (Pediatric) | Orally disintegrable tablets |
Nov 17, 2019
(Expired) | Takeda Pharms Usa |
| Prevacid |
US9901546 (Pediatric) | Orally disintegrable tablets |
Nov 17, 2019
(Expired) | Takeda Pharms Usa |
| Prevacid | US6328994 | Orally disintegrable tablets |
May 17, 2019
(Expired) | Takeda Pharms Usa |
| Prevacid | US7431942 | Orally disintegrable tablets |
May 17, 2019
(Expired) | Takeda Pharms Usa |
| Prevacid | US7875292 | Orally disintegrable tablets |
May 17, 2019
(Expired) | Takeda Pharms Usa |
| Prevacid | US9901546 | Orally disintegrable tablets |
May 17, 2019
(Expired) | Takeda Pharms Usa |
| Prevacid |
US7399485 (Pediatric) | Rapidly Disintegrable solid preparation |
Nov 26, 2018
(Expired) | Takeda Pharms Usa |
| Prevacid | US7399485 | Rapidly Disintegrable solid preparation |
May 26, 2018
(Expired) | Takeda Pharms Usa |
| Prevacid |
US5464632 (Pediatric) | Rapidly disintegratable multiparticular tablet |
May 07, 2013
(Expired) | Takeda Pharms Usa |
| Prevacid | US5464632 | Rapidly disintegratable multiparticular tablet |
Nov 07, 2012
(Expired) | Takeda Pharms Usa |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Lansoprazole's patents.
Latest Legal Activities on Lansoprazole's Patents
Given below is the list recent legal activities going on the following patents of Lansoprazole.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Patent Issue Date Used in PTA Calculation Critical | 03 Aug, 2021 | US11077055 |
| Recordation of Patent Grant Mailed Critical | 03 Aug, 2021 | US11077055 |
| Email Notification Critical | 15 Jul, 2021 | US11077055 |
| Issue Notification Mailed Critical | 14 Jul, 2021 | US11077055 |
| Dispatch to FDC | 28 Jun, 2021 | US11077055 |
| Application Is Considered Ready for Issue Critical | 28 Jun, 2021 | US11077055 |
| Issue Fee Payment Verified Critical | 23 Jun, 2021 | US11077055 |
| Issue Fee Payment Received Critical | 23 Jun, 2021 | US11077055 |
| Electronic Review Critical | 19 Jun, 2021 | US11077055 |
| Email Notification Critical | 18 Jun, 2021 | US11077055 |
Lansoprazole's Family Patents
Explore Our Curated Drug Screens
Lansoprazole Generic API Manufacturers
Several generic applications have been filed for Lansoprazole. The first generic version for Lansoprazole was by Teva Pharmaceuticals Usa and was approved on Nov 10, 2009. And the latest generic version is by Macleods Pharmaceuticals Ltd and was approved on Nov 4, 2024.
Given below is the list of companies who have filed for Lansoprazole generic, along with the locations of their manufacturing plants worldwide.
1. AJANTA PHARMA LTD
Ajanta Pharma Ltd has filed for 2 different strengths of generic version for Lansoprazole. Given below are the details of the strengths of this generic introduced by Ajanta Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 15MG | capsule, delayed rel pellets | Discontinued | ORAL | N/A | Oct 14, 2016 |
| 30MG | capsule, delayed rel pellets | Discontinued | ORAL | N/A | Oct 14, 2016 |
Manufacturing Plant Locations New
Ajanta Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Ajanta Pharma Ltd as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
2. ALKEM LABS LTD
Alkem Laboratories Ltd has filed for 2 different strengths of generic version for Lansoprazole. Given below are the details of the strengths of this generic introduced by Alkem Labs Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 30MG | capsule, delayed rel pellets | Prescription | ORAL | AB | Jan 18, 2019 |
| 15MG | capsule, delayed rel pellets | Prescription | ORAL | AB | Jan 18, 2019 |
3. ANI PHARMS
Ani Pharmaceuticals Inc has filed for 2 different strengths of generic version for Lansoprazole. Given below are the details of the strengths of this generic introduced by Ani Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 15MG | tablet, orally disintegrating, delayed release | Discontinued | ORAL | N/A | Oct 15, 2010 |
| 30MG | tablet, orally disintegrating, delayed release | Discontinued | ORAL | N/A | Oct 15, 2010 |
4. AUROBINDO PHARMA LTD
Aurobindo Pharma Ltd has filed for 2 different strengths of generic version for Lansoprazole. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 15MG | tablet, orally disintegrating, delayed release | Prescription | ORAL | AB | Mar 28, 2023 |
| 30MG | tablet, orally disintegrating, delayed release | Prescription | ORAL | AB | Mar 28, 2023 |
Manufacturing Plant Locations New
Aurobindo Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma Ltd as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
5. BRECKENRIDGE
Breckenridge Pharmaceutical Inc has filed for 2 different strengths of generic version for Lansoprazole. Given below are the details of the strengths of this generic introduced by Breckenridge.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 15MG | capsule, delayed rel pellets | Discontinued | ORAL | N/A | Oct 17, 2018 |
| 30MG | capsule, delayed rel pellets | Discontinued | ORAL | N/A | Oct 17, 2018 |
Manufacturing Plant Locations New
Breckenridge's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Breckenridge as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| United States |
| |||||
6. CHARTWELL MOLECULAR
Chartwell Molecular Holdings Llc has filed for 2 different strengths of generic version for Lansoprazole. Given below are the details of the strengths of this generic introduced by Chartwell Molecular.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 15MG | capsule, delayed rel pellets | Prescription | ORAL | AB | Sep 28, 2017 |
| 30MG | capsule, delayed rel pellets | Prescription | ORAL | AB | Sep 28, 2017 |
7. DR REDDYS
Dr Reddys Laboratories Ltd has filed for 2 different strengths of generic version for Lansoprazole. Given below are the details of the strengths of this generic introduced by Dr Reddys.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 30MG | tablet, orally disintegrating, delayed release | Prescription | ORAL | AB | Feb 1, 2021 |
| 15MG | tablet, orally disintegrating, delayed release | Prescription | ORAL | AB | Feb 1, 2021 |
8. DR REDDYS LABS LTD
Dr Reddys Laboratories Ltd has filed for 2 different strengths of generic version for Lansoprazole. Given below are the details of the strengths of this generic introduced by Dr Reddys Labs Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 15MG | capsule, delayed rel pellets | Over the counter | ORAL | N/A | May 18, 2012 |
| 30MG | capsule, delayed rel pellets | Prescription | ORAL | AB | Oct 15, 2010 |
9. GLENMARK PHARMS INC
Glenmark Pharmaceuticals Inc Usa has filed for 1 generic for Lansoprazole. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 15MG | capsule, delayed rel pellets | Over the counter | ORAL | N/A | May 18, 2012 |
10. HETERO LABS LTD III
Hetero Labs Ltd Unit Iii has filed for 2 different strengths of generic version for Lansoprazole. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd Iii.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 15MG | capsule, delayed rel pellets | Prescription | ORAL | AB | May 18, 2020 |
| 30MG | capsule, delayed rel pellets | Prescription | ORAL | AB | May 18, 2020 |
11. INVENTIA
Inventia Healthcare Ltd has filed for 2 different strengths of generic version for Lansoprazole. Given below are the details of the strengths of this generic introduced by Inventia.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 30MG | capsule, delayed rel pellets | Prescription | ORAL | AB | Aug 30, 2017 |
| 15MG | capsule, delayed rel pellets | Prescription | ORAL | AB | Aug 30, 2017 |
Manufacturing Plant Locations New
Inventia's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Inventia as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| India |
| |||||
12. KRKA TOVARNA ZDRAVIL
Krka Tovarna Zdravil Dd Novo Mesto has filed for 2 different strengths of generic version for Lansoprazole. Given below are the details of the strengths of this generic introduced by Krka Tovarna Zdravil.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 30MG | capsule, delayed rel pellets | Discontinued | ORAL | N/A | Sep 16, 2013 |
| 15MG | capsule, delayed rel pellets | Discontinued | ORAL | N/A | Sep 16, 2013 |
13. LANNETT CO INC
Lannett Co Inc has filed for 1 generic for Lansoprazole. Given below are the details of the strengths of this generic introduced by Lannett Co Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 15MG | capsule, delayed rel pellets | Discontinued | ORAL | N/A | Sep 29, 2017 |
14. MACLEODS PHARMS LTD
Macleods Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Lansoprazole. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 15MG | capsule, delayed rel pellets | Prescription | ORAL | AB | Nov 4, 2024 |
| 30MG | capsule, delayed rel pellets | Prescription | ORAL | AB | Nov 4, 2024 |
15. MYLAN
Mylan Pharmaceuticals Inc has filed for 2 different strengths of generic version for Lansoprazole. Given below are the details of the strengths of this generic introduced by Mylan.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 15MG | tablet, orally disintegrating, delayed release | Prescription | ORAL | AB | Nov 28, 2018 |
| 30MG | tablet, orally disintegrating, delayed release | Prescription | ORAL | AB | Nov 28, 2018 |
Manufacturing Plant Locations New
Mylan's manufacturing plants are situated in 4 countries - United States, India, Canada, Ireland. Given below are the details of these plant locations as well as the firm names of Mylan as present at those locations.
| Country | City | Firm Name | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||
| India |
| |||||||||||||||||
| Canada |
| |||||||||||||||||
| Ireland |
| |||||||||||||||||
16. MYLAN PHARMS INC
Mylan Pharmaceuticals Inc has filed for 2 different strengths of generic version for Lansoprazole. Given below are the details of the strengths of this generic introduced by Mylan Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 15MG | capsule, delayed rel pellets | Prescription | ORAL | AB | Nov 10, 2009 |
| 30MG | capsule, delayed rel pellets | Prescription | ORAL | AB | Nov 10, 2009 |
17. NATCO
Natco Pharma Ltd has filed for 1 generic for Lansoprazole. Given below are the details of the strengths of this generic introduced by Natco.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 15MG | capsule, delayed rel pellets | Over the counter | ORAL | N/A | Jan 13, 2016 |
Manufacturing Plant Locations New
Natco's manufacturing plants are situated in 2 countries - United Kingdom, India. Given below are the details of these plant locations as well as the firm names of Natco as present at those locations.
| Country | City | Firm Name | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United Kingdom |
| |||||||||||||
| India |
| |||||||||||||
18. NATCO PHARMA LTD
Natco Pharma Ltd has filed for 2 different strengths of generic version for Lansoprazole. Given below are the details of the strengths of this generic introduced by Natco Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 15MG | capsule, delayed rel pellets | Prescription | ORAL | AB | Dec 18, 2012 |
| 30MG | capsule, delayed rel pellets | Prescription | ORAL | AB | Dec 18, 2012 |
Manufacturing Plant Locations New
Natco Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Natco Pharma Ltd as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| India |
| |||||
19. PERRIGO R AND D
Perrigo R And D Co has filed for 1 generic for Lansoprazole. Given below are the details of the strengths of this generic introduced by Perrigo R And D.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 15MG | capsule, delayed rel pellets | Over the counter | ORAL | N/A | May 18, 2012 |
20. SANDOZ
Sandoz Inc has filed for 2 different strengths of generic version for Lansoprazole. Given below are the details of the strengths of this generic introduced by Sandoz.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 15MG | capsule, delayed rel pellets | Discontinued | ORAL | N/A | Apr 23, 2010 |
| 30MG | capsule, delayed rel pellets | Discontinued | ORAL | N/A | Apr 23, 2010 |
Manufacturing Plant Locations New
Sandoz's manufacturing plants are situated in 4 countries - Austria, United States, Spain, India. Given below are the details of these plant locations as well as the firm names of Sandoz as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| Austria |
| |||||
| United States |
| |||||
| Spain |
| |||||
| India |
| |||||
21. SUN PHARM
Sun Pharmaceutical Industries Ltd has filed for 2 different strengths of generic version for Lansoprazole. Given below are the details of the strengths of this generic introduced by Sun Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 15MG | capsule, delayed rel pellets | Discontinued | ORAL | N/A | Sep 13, 2013 |
| 30MG | capsule, delayed rel pellets | Discontinued | ORAL | N/A | Sep 13, 2013 |
Manufacturing Plant Locations New
Sun Pharm's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Sun Pharm as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||||||||||||||
| India |
| |||||||||||||||||||||||||||||
22. TEVA PHARMS
Teva Pharmaceuticals Usa has filed for 2 different strengths of generic version for Lansoprazole. Given below are the details of the strengths of this generic introduced by Teva Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 30MG | capsule, delayed rel pellets | Prescription | ORAL | AB | Nov 10, 2009 |
| 15MG | capsule, delayed rel pellets | Prescription | ORAL | AB | Nov 10, 2009 |
23. TEVA PHARMS USA
Teva Pharmaceuticals Usa has filed for 2 different strengths of generic version for Lansoprazole. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 30MG | tablet, orally disintegrating, delayed release | Prescription | ORAL | AB | Sep 21, 2017 |
| 15MG | tablet, orally disintegrating, delayed release | Prescription | ORAL | AB | Sep 21, 2017 |
24. WOCKHARDT
Wockhardt Ltd has filed for 2 different strengths of generic version for Lansoprazole. Given below are the details of the strengths of this generic introduced by Wockhardt.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 15MG | capsule, delayed rel pellets | Prescription | ORAL | AB | Sep 14, 2012 |
| 30MG | capsule, delayed rel pellets | Prescription | ORAL | AB | Sep 14, 2012 |
Manufacturing Plant Locations New
Wockhardt's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Wockhardt as present at those locations.
| Country | City | Firm Name | ||||||
|---|---|---|---|---|---|---|---|---|
| India |
| |||||||
25. XIROMED
Xiromed Pharma Espana Sl has filed for 2 different strengths of generic version for Lansoprazole. Given below are the details of the strengths of this generic introduced by Xiromed.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 15MG | capsule, delayed rel pellets | Prescription | ORAL | AB | Jul 25, 2016 |
| 30MG | capsule, delayed rel pellets | Prescription | ORAL | AB | Jul 25, 2016 |
Manufacturing Plant Locations New
Xiromed's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Xiromed as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| United States |
| |||
26. ZYDUS HLTHCARE
Zydus Healthcare Usa Llc has filed for 2 different strengths of generic version for Lansoprazole. Given below are the details of the strengths of this generic introduced by Zydus Hlthcare.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 30MG | capsule, delayed rel pellets | Prescription | ORAL | AB | Aug 19, 2013 |
| 15MG | capsule, delayed rel pellets | Prescription | ORAL | AB | Aug 19, 2013 |
27. ZYDUS PHARMS
Zydus Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Lansoprazole. Given below are the details of the strengths of this generic introduced by Zydus Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 30MG | tablet, orally disintegrating, delayed release | Prescription | ORAL | AB | Nov 27, 2018 |
| 15MG | tablet, orally disintegrating, delayed release | Prescription | ORAL | AB | Nov 27, 2018 |